ALT logo

Altimmune (ALT) CAPEX

Annual CAPEX

$47.00 K
-$79.00 K-62.70%

December 31, 2023

Summary

Performance

1-Year Change

-62.7%

3-Year Change

-86.27%

5-Year Change

-95.37%

15-Year Change

-71.74%

ALT CAPEX Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

8.29%
ALT annual capital expenditures is higher than 8.29% of companies in Healthcare sector

High & Low

All-time High

$12.31 M
ALT annual capital expenditures is currently -99.62% below its historical high of $12.31 million

3-Year Low

$47.00 K
ALT annual capital expenditures is currently at its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2023
ALT previous annual earnings announcement was published on Dec 31, 2023

Next Annual Earnings Report Date

Mar 27, 2025
ALT next annual earnings announcement is scheduled for Mar 27, 2025

OtherALTcash flowmetrics:

Annual FCF

-$75.86 M
ALT annual free cash flow is -$75.86 million

Annual CFO

-$75.81 M
ALT annual cash flow from operations is -$75.81 million

Annual CFI

$13.73 M
ALT annual cash flow from investing activities is $13.73 million

Annual CFF

$86.11 M
ALT annual cash flow from financing activities is $86.11 million

Quarterly CAPEX

N/A

September 30, 2024

Summary

Performance

3-Month Change

-

1-Year Change

-

3-Year Change

-

5-Year Change

-

ALT Quarterly CAPEX Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$7.77 M
ALT quarterly capital expenditures is currently at an all-time high

3-Year Low

-$4000.00
ALT quarterly capital expenditures is currently at its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
ALT previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Mar 27, 2025
ALT next earnings announcement is scheduled for Mar 27, 2025

OtherALTcash flowmetrics:

Quarterly FCF

-$27.12 M
ALT quarterly free cash flow is -$27.12 million

Quarterly CFO

-$27.12 M
ALT quarterly cash flow from operations is -$27.12 million

Quarterly CFI

$1.20 M
ALT quarterly cash flow from investing activities is $1.20 million

Quarterly CFF

$266.00 K
ALT quarterly cash flow from financing activities is $266.00 thousand

TTM CAPEX

N/A

September 30, 2024

Summary

Performance

3-Month Change

-

1-Year Change

-

3-Year Change

-

5-Year Change

-

ALT TTM CAPEX Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$12.31 M
ALT TTM capital expenditures is currently at an all-time high

3-Year Low

$47.00 K
ALT TTM capital expenditures is currently at its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
ALT previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Mar 27, 2025
ALT next earnings announcement is scheduled for Mar 27, 2025

OtherALTcash flowmetrics:

TTM FCF

-$78.12 M
ALT TTM free cash flow is -$78.12 million

TTM CFO

-$78.12 M
ALT TTM cash flow from operations is -$78.12 million

TTM CFI

-$49.98 M
ALT TTM cash flow from investing activities is -$49.98 million

TTM CFF

$72.71 M
ALT TTM cash flow from financing activities is $72.71 million

ALT CAPEX Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-62.7%--
3 y3 years-86.3%--
5 y5 years-95.4%--

ALT CAPEX Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-99.6%at low
5 y5-year-99.6%+62.1%
alltimeall time-99.6%+62.1%

Altimmune CAPEX History

DateAnnualQuarterlyTTM
Dec 2023
$47.00 K(-62.7%)
$0.00(0.0%)
$47.00 K(-44.7%)
Sep 2023
-
$0.00(-100.0%)
$85.00 K(-41.4%)
Jun 2023
-
-$4000.00(-107.8%)
$145.00 K(-13.7%)
Mar 2023
-
$51.00 K(+34.2%)
$168.00 K(+33.3%)
Dec 2022
$126.00 K(-99.0%)
$38.00 K(-36.7%)
$126.00 K(-47.5%)
Sep 2022
-
$60.00 K(+215.8%)
$240.00 K(-18.6%)
Jun 2022
-
$19.00 K(+111.1%)
$295.00 K(-96.3%)
Mar 2022
-
$9000.00(-94.1%)
$8.05 M(-34.6%)
Dec 2021
$12.31 M(+3495.8%)
$152.00 K(+32.2%)
$12.31 M(+0.1%)
Sep 2021
-
$115.00 K(-98.5%)
$12.30 M(+0.3%)
Jun 2021
-
$7.77 M(+82.0%)
$12.27 M(+168.1%)
Mar 2021
-
$4.27 M(+2882.5%)
$4.58 M(+1236.4%)
Dec 2020
$342.40 K(+1080.7%)
$143.20 K(+80.6%)
$342.40 K(+69.8%)
Sep 2020
-
$79.30 K(-3.8%)
$201.60 K(+53.0%)
Jun 2020
-
$82.40 K(+119.7%)
$131.80 K(+111.6%)
Mar 2020
-
$37.50 K(+1462.5%)
$62.30 K(+114.8%)
Dec 2019
$29.00 K(-97.1%)
$2400.00(-74.7%)
$29.00 K(-16.4%)
Sep 2019
-
$9500.00(-26.4%)
$34.70 K(-82.1%)
Jun 2019
-
$12.90 K(+207.1%)
$193.50 K(-45.1%)
Mar 2019
-
$4200.00(-48.1%)
$352.30 K(-65.3%)
Dec 2018
$1.02 M(+510.7%)
$8100.00(-95.2%)
$1.02 M(-2.0%)
Sep 2018
-
$168.30 K(-2.0%)
$1.04 M(+16.3%)
Jun 2018
-
$171.70 K(-74.3%)
$891.00 K(+14.7%)
Mar 2018
-
$667.50 K(+2217.7%)
$776.90 K(+367.2%)
Dec 2017
$166.30 K(-24.6%)
$28.80 K(+25.2%)
$166.30 K(-6.9%)
Sep 2017
-
$23.00 K(-60.1%)
$178.70 K(-35.0%)
Jun 2017
-
$57.60 K(+1.2%)
$275.10 K(-0.8%)
Mar 2017
-
$56.90 K(+38.1%)
$277.20 K(+25.8%)
Dec 2016
$220.60 K
$41.20 K(-65.5%)
$220.40 K(+11.7%)
Sep 2016
-
$119.40 K(+100.0%)
$197.40 K(+119.3%)
Jun 2016
-
$59.70 K(>+9900.0%)
$90.00 K(+75.8%)
DateAnnualQuarterlyTTM
Mar 2016
-
$100.00(-99.5%)
$51.20 K(-40.8%)
Dec 2015
$86.50 K(-6.3%)
$18.20 K(+51.7%)
$86.50 K(+26.6%)
Sep 2015
-
$12.00 K(-42.6%)
$68.30 K(-1.4%)
Jun 2015
-
$20.90 K(-41.0%)
$69.30 K(-23.5%)
Mar 2015
-
$35.40 K(>+9900.0%)
$90.60 K(-1.7%)
Dec 2014
$92.30 K(+9.1%)
$0.00(-100.0%)
$92.20 K(0.0%)
Sep 2014
-
$13.00 K(-69.2%)
$92.20 K(-1.1%)
Jun 2014
-
$42.20 K(+14.1%)
$93.20 K(-3.0%)
Mar 2014
-
$37.00 K(>+9900.0%)
$96.10 K(+13.6%)
Dec 2013
$84.60 K(+18.5%)
$0.00(-100.0%)
$84.60 K(0.0%)
Sep 2013
-
$14.00 K(-69.0%)
$84.60 K(+19.8%)
Jun 2013
-
$45.10 K(+76.9%)
$70.60 K(+176.9%)
Mar 2013
-
$25.50 K(>+9900.0%)
$25.50 K(-64.3%)
Dec 2011
$71.40 K(-80.9%)
$0.00(-100.0%)
$71.50 K(-41.2%)
Sep 2011
-
$41.10 K(+35.2%)
$121.50 K(+74.6%)
Jun 2011
-
$30.40 K(-39.2%)
$69.60 K(-81.4%)
Dec 2010
$374.60 K(-63.6%)
$50.00 K(-563.0%)
$374.60 K(-301.9%)
Sep 2010
-
-$10.80 K(-119.3%)
-$185.50 K(-147.1%)
Jun 2010
-
$55.90 K(-80.0%)
$393.90 K(-66.0%)
Mar 2010
-
$279.50 K(-154.8%)
$1.16 M(+12.4%)
Dec 2009
$1.03 M(+102.1%)
-$510.10 K(-189.7%)
$1.03 M(-35.4%)
Sep 2009
-
$568.60 K(-30.6%)
$1.59 M(+39.7%)
Jun 2009
-
$818.90 K(+438.8%)
$1.14 M(+106.0%)
Mar 2009
-
$152.00 K(+181.0%)
$554.00 K(+8.8%)
Dec 2008
$509.30 K(-42.3%)
$54.10 K(-53.4%)
$509.40 K(+11.9%)
Sep 2008
-
$116.10 K(-49.9%)
$455.30 K(+34.2%)
Jun 2008
-
$231.80 K(+115.8%)
$339.20 K(+215.8%)
Mar 2008
-
$107.40 K(-56.6%)
$107.40 K(-89.6%)
Dec 2007
$882.30 K(+12.2%)
-
-
Mar 2007
-
$247.30 K(-21.0%)
$1.03 M(+31.4%)
Dec 2006
$786.50 K
$313.20 K(-33.8%)
$786.50 K(+66.2%)
Sep 2006
-
$473.30 K
$473.30 K

FAQ

  • What is Altimmune annual capital expenditures?
  • What is the all time high annual CAPEX for Altimmune?
  • What is Altimmune annual CAPEX year-on-year change?
  • What is the all time high quarterly CAPEX for Altimmune?
  • What is the all time high TTM CAPEX for Altimmune?

What is Altimmune annual capital expenditures?

The current annual CAPEX of ALT is $47.00 K

What is the all time high annual CAPEX for Altimmune?

Altimmune all-time high annual capital expenditures is $12.31 M

What is Altimmune annual CAPEX year-on-year change?

Over the past year, ALT annual capital expenditures has changed by -$79.00 K (-62.70%)

What is the all time high quarterly CAPEX for Altimmune?

Altimmune all-time high quarterly capital expenditures is $7.77 M

What is the all time high TTM CAPEX for Altimmune?

Altimmune all-time high TTM capital expenditures is $12.31 M